Incyte (INCY) grants RSUs, options and performance shares to EVP
Rhea-AI Filing Summary
INCYTE CORP executive Mohamed Khairie Issa, EVP and Head of U.S. Commercial, reported equity grants and a small stock sale. He received 7,857 restricted stock units vesting 25% annually over four years, for a total of 71,797 unvested RSU-based shares, plus 33,918 stock options at an exercise price of $116.65 and 19,643 performance shares linked to relative total shareholder return. On the same date, he sold 1,093 common shares at $115.01, leaving 63,940 shares held directly. The filing indicates these transactions were effected under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Buyer: 6,764 shares
Net Buy
4 txns
Insider
Issa Mohamed Khairie
Role
EVP, Head of U.S. Commercial
Sold
1,093 shs ($126K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Shares F3 | 19,643 | $0.00 | -- |
| Grant/Award | Employee Stock Option (right to buy) F4 | 33,918 | $0.00 | -- |
| Sale | Common Stock | 1,093 | $115.01 | $126K |
| Grant/Award | Common Stock F1, F2 | 7,857 | $0.00 | -- |
Holdings After Transaction:
Performance Shares — 19,643 shares (Direct);
Employee Stock Option (right to buy) — 33,918 shares (Direct);
Common Stock — 71,797 shares (Direct)
Footnotes (4)
- F1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- F2. Including the July 16, 2026 grant, this includes an aggregate of 71,797 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
- F4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:
Key Figures
RSUs granted: 7,857 shares
Unvested RSU-based shares: 71,797 shares
Shares sold: 1,093 shares
+4 more
7 metrics
RSUs granted
7,857 shares
Restricted stock units granted on July 16, 2026, vesting 25% annually over four years
Unvested RSU-based shares
71,797 shares
Total shares of common stock issuable from unvested RSUs after the July 16, 2026 grant
Shares sold
1,093 shares
Common stock sold on July 16, 2026 in an open market or private transaction
Sale price
$115.01 per share
Price received per share for the 1,093 common shares sold
Direct holdings after sale
63,940 shares
Common shares of INCYTE CORP held directly by Issa after the July 16, 2026 sale
Stock options granted
33,918 options at $116.65
Employee stock options granted on July 16, 2026 with a $116.65 exercise price, expiring July 15, 2036
Performance shares granted
19,643 units
Performance shares tied to three-year relative total shareholder return starting January 1, 2026
Key Terms
restricted stock units, Performance Shares, total shareholder return ("TSR"), Rule 10b5-1 trading plan
4 terms
restricted stock units financial
"Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Rule 10b5-1 trading plan financial
"The filing indicates these transactions were effected under a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did INCYTE CORP (INCY) grant to Mohamed Khairie Issa?
Mohamed Khairie Issa received 7,857 RSUs, 33,918 employee stock options at $116.65 per share, and 19,643 performance shares on July 16, 2026, as part of his equity compensation package from INCYTE CORP.
What is the vesting schedule for Mohamed Khairie Issa’s INCY restricted stock units?
The 7,857 RSUs granted to Mohamed Khairie Issa vest 25% each year over four years. Including this grant, RSUs cover 71,797 shares of common stock that remain unvested and will settle one-for-one in shares when they vest.
What are the terms of Mohamed Khairie Issa’s new INCY stock options?
He was granted 33,918 stock options with a strike price of $116.65 per share, expiring on July 15, 2036. The options vest in 37 installments, with 25% after one year and the remainder vesting monthly over the next three years.
Were Mohamed Khairie Issa’s INCY transactions under a Rule 10b5-1 trading plan?
Yes. The Form 4 indicates the reported transactions were effected under a Rule 10b5-1 trading plan, meaning trades, including the 1,093-share sale, were executed pursuant to a pre-arranged trading arrangement.